Frequently asked questions

Click on a link below to view answers to frequently asked questions about asthma and PULMICORT RESPULES.

About PULMICORT RESPULES—find answers to frequently asked questions about using PULMICORT RESPULES, how to administer the medicine and side effects

About Nebulizers—find answers to frequently asked questions about using and caring for your nebulizer

Inhaled Corticosteriods—find answers to frequently asked questions about inhaled corticosteroids

About Asthma—find answers to frequently asked questions about asthma and related symptoms, triggers, and treatment options

Working with Your Doctor—find answers to frequently asked questions about working with your doctor

PULMICORT RESPULES is developed and approved specifically for children 12 months to 8 years of age, to help prevent asthma symptoms that could lead to an attack. PULMICORT RESPULES, an inhaled corticosteroid, is not a quick-relief medication and should NOT be used to treat an acute (sudden) asthma attack.

Important Safety Information you should know

PULMICORT RESPULES, an inhaled corticosteroid, is not a quick-relief medication and should NOT be used to treat an acute asthma attack. In studies, side effects included respiratory infection, runny nose, earache, and coughing. Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult height is unknown. If switching to PULMICORT RESPULES from an oral (syrup or pill) corticosteroid, follow the doctor's instructions to help avoid health risks. Tell the doctor if your child is exposed to chicken pox or measles.

Click here for full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

References

  1. Agertoft L, Pedersen, S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000; 343:1064-9.
  2. Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol. 1999;104:200-209.
  3. American Academy of Allergy & Immunology. Tips to Remember: Asthma triggers and management. Available at: http://www.aaaai.org/patients/publicedmat/tips/
    asthmatriggersandmgmt.stm    . Accessed October 20, 2006.